Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Hematology | Cardiology/Vascular Diseases | Family Medicine
Disease Category: Stroke
Location: United States, FL
A Double-Blind, Controlled Phase 2B Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Ischemic Stroke
This study is being conducted to determine the safety and efficacy of stem cells administered by injection into the brain around the area of the stroke.
CW ID: 213739
Date Last Changed:
March 23, 2016
Tara McTigueUniversity of South Florida - South Tampa Center for Advanced Healthcare2 Tampa General CircleTampa, FL 33606
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.